Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gerald H J Mickisch"'
Autor:
Richard Sylvester, Linda de Prijck, Hendrik Van Poppel, P.F.A. Mulders, Allan T. van Oosterom, Nina Aass, Pieter H.M. de Mulder, Gerald H J Mickisch, Sophie D. Fosså
Publikováno v:
Journal of Clinical Oncology, 23, 4172-8
Journal of Clinical Oncology, 23, 18, pp. 4172-8
Journal of Clinical Oncology, 23, 18, pp. 4172-8
Purpose A randomized phase II/III trial was conducted to determine whether combination treatment with 13-cis-retinoic acid (13-CRA) plus interferon alfa-2a (IFN-α-2a) was superior to IFN-α-2a alone in patients with progressive metastatic renal cell
Autor:
Joaquim Bellmunt, Camillo Porta, B. Schwander, Gerald H J Mickisch, J. P. Maroto, Uwe Siebert, Bernard Escudier, Stefan Walzer
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Gerald HJ Mickisch1, Björn Schwander2, Bernard Escudier3, Joaquim Bellmunt4, José P Maroto5, Camillo Porta6, Stefan Walzer7, Uwe Siebert8,91Department of Urology, Center of Operative Urology Bremen, Bremen, Germany; 2Department of Outcomes Research
Autor:
Sophie D, Fosså, Gerald H J, Mickisch, Pieter H M, De Mulder, Simon, Horenblas, Allan T, van Oosterom, Hein, van Poppel, Martin, Fey, Jelle J, Croles, Linda, de Prijck, Martine, Van Glabbeke
Publikováno v:
Cancer. 101(3)
In patients with metastatic renal cell carcinoma (MRCC), interferon-alpha (IFN) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. In 1995, preclinical and clinical data indicated an improvement of these results if
Autor:
Sophie D. Fosså, Gerald H. J. Mickisch, Pieter H. M. De Mulder, Simon Horenblas, Allan T. van Oosterom, Hein van Poppel, Martin Fey, Jelle J. Croles, Linda de Prijck, Martine Van Glabbeke
Publikováno v:
Cancer (0008543X); Aug2004, Vol. 101 Issue 3, p533-540, 8p